Pentagon Rescinds Testosterone Screening Guidance for Updates
The Pentagon has temporarily rescinded its new policy mandating testosterone screening for military personnel. The withdrawal follows shortly after the guidance document's release, with the department citing the need for updates.
The U.S. Department of Defense has withdrawn its new policy that would have required mandatory testosterone screening for military personnel. The decision came just one day after a detailed clinical guidance document was released, following Defense Secretary Pete Hegseth's July announcement.
The guidance document and an accompanying statement disappeared from the Pentagon's website the day after its publication. The withdrawal was first reported by Reuters. The Pentagon stated that the document, titled "Clinical Guidance for Health and Human Performance Optimization," was temporarily rescinded to allow for updates.
At this time, there is no information on when an updated guidance will be released or what changes it might entail. The reasons behind the swift withdrawal of the policy have not been further elaborated upon.
The original guidance was set to take effect in early September, aiming to optimize the health and performance of military personnel. The policy's withdrawal has raised questions regarding its scientific basis and potential implications for service members' health and careers.